International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 1 (January-February 2026) Submit your research before last 3 days of February to publish your research paper in the issue of January-February.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 1
January-February 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Cutaneous Adverse Effects of Beta-blockers: A Case of Psoriasis induced by Nebivolol

Author(s) Dr. Sahla Sainudeen, Dr. Rency Abraham, Dr. Lissy Skaria
Country India
Abstract Nebivolol comes under the class of cardio selective Beta-blockers. Beta blockers are a very popular class of drugs used to treat both cardiovascular and non-cardiovascular diseases, including hypertension, ischaemic heart disease, arrhythmias, heart failure, hyperthyroidism, glaucoma, and anxiety disorders. Typically prescribed for high blood pressure, beta-blockers are among the drugs most commonly linked to psoriasis. Psoriasis is a complex, chronic, multifactorial, inflammatory disease that involves hyper-proliferation of the keratinocytes in the epidermis, with an increase in the epidermal cell turnover rate. This case report describes a 70 years old male with hypertrophic cardiomyopathy, Dyslipidemia, Coronary Artery Disease and systemic hypertension who developed psoriasis due to administration of nebivolol, a beta blocker used to manage HTN. The patient came with complaints of itchy erythematous scaly plaques with erosions over scalp, trunk and extremities for 1 month. Discontinuation of beta blockers such as nebivolol was advised. This case highlights our attention to the potential dermatologic adverse effects that may follow with a beta-blocker use, as well as proper reviewing of medical history for any allergic reactions and the optimization of drug therapy in order to avoid such drug-induced flares.
Keywords Nebivolol, Beta-blockers, Psoriasiform dermatitis, Adverse drug reaction, Hypertension
Field Medical / Pharmacy
Published In Volume 7, Issue 4, July-August 2025
Published On 2025-08-13
DOI https://doi.org/10.36948/ijfmr.2025.v07i04.53292
Short DOI https://doi.org/g9w5dm
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 1Cover Page Vol 7 Isu 6Cover Page Vol 7 Isu 5

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com